NCT05999630View on ClinicalTrials.gov

Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated with Radioactive Iodine for Thyroid Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 21, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Nasolacrimal Duct ObstructionThyroid Cancer
Interventions
DRUG

Artificial Tears Methylcellulose

Participants will self-administer the artificial tears according to the schedule.

Trial Locations (1)

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER